Q3

INDOCO REMEDIES LTD.

INDOCOFY2603 Feb 2026

Revenue-8.1%

Net Profit-219.8%

OPM5.69%

P&L

Quarterly Consolidated

Revenue

-8.1%445.36

Expenditure

-5.4%471.50

Net Profit

-219.8%-29.45

NPM -6.60%-247.4%EPS ₹3.20+220.0%

vs Q2 FY26

Informational and educational content only. Not investment advice.